参考文献/References:
[1] HUANG Y,BADURDEEN D S.Acute pancreatitis review[J].Turk J Gastroenterol,2023,34(8):795-801.
[2] SCURT F G,BOSE K,CANBAY A,et al.Acute kidney injury following acute pancreatitis(AP-AKI):Definition,pathophysiology,diagnosis and therapy[J].Z Gastroenterol,2020,58(12):1241-1266.
[3] 刘显荣,马能前,龙建武,等.激活素A早期识别中重症急性胰腺炎的临床价值[J].中华危重病急救医学,2022,34(7):732-735.
[4] 孙越晨,叶莉莉,严双凤.乳酸脱氢酶与白蛋白比值与脓毒性休克患者预后的关系[J].现代实用医学,2024,36(3):308-311.
[5] TURUNEN A,KUULIALA K,KUULIALA A,et al.Activated matrix metalloproteinase 8 in serum predicts severity of acute pancreatitis[J].Pancreatology,2021,21(5):862-869.
[6] 中华医学会外科学分会胰腺外科学组.中国急性胰腺炎诊治指南(2021)[J].中华外科杂志,2021,59(7):578-587.
[7] 王真珍,邬明杰,方雪玲,等.急性生理和慢性健康评分Ⅱ对成人复杂腹腔感染死亡预测准确性的荟萃分析[J].中国感染与化疗杂志,2018,18(4):345-351.
[8] BANKS P A,BOLLEN T L,DERWENIS C,et al.Classification of acute pancreatitis—2012:Revision of the Atlanta classification and definitions by international consensus[J].Gut,2013,62(1):102-111.
[9] 朱芳丽,马厉英,马晓莹,等.急性胰腺炎患者血清CXC趋化因子配体10和CC类趋化因子22水平与疾病严重程度关系及临床诊断价值研究[J].陕西医学杂志,2024,53(6):788-792.
[10] 龙丹丹,姜爽.清胆解毒汤合四逆散治疗急性胰腺炎肝胆湿热证临床研究[J].陕西中医,2024,45(6):767-770.
[11] 楼立君,李人龙,李雁,等.吲哚美辛通过恢复自噬流减轻雨蛙素诱导的小鼠急性胰腺炎[J].空军军医大学学报,2024,45(3):263-269.
[12] 韩文君,李晓凡,李欣,等.乌司他丁联合序贯透析及持续血液滤过治疗重症急性胰腺炎脓毒症休克的临床效果[J].临床误诊误治,2024,37(20):87-90.
[13] CHAN K S,SHELAT V G.Diagnosis,severity stratification and management of adult acute pancreatitis-current evidence and controversies[J].World J Gastrointest Surg,2022,14(11):1179-1197.
[14] ALZERWI N.Surgical management of acute pancreatitis:Historical perspectives,challenges,and current management approaches[J].World J Gastrointest Surg,2023,15(3):307-322.
[15] MORIANOS I,PAPADOPOULOU G,SEMITEKOLOU M,et al.Activin-A in the regulation of immunity in health and disease[J].J Autoimmun,2019,104:102314.
[16] LODLBERG A.Principles of the activin receptor signaling pathway and its inhibition[J].Cytokine Growth Factor Rev,2021,60:1-17.
[17] GLAUBITZ J,WILDEN A,GOLCHERT J,et al.In mouse chronic pancreatitis CD25+FOXP3+ regulatory T cells control pancreatic fibrosis by suppression of the type 2 immune response[J].Nat Commun,2022,13(1):4502.
[18] THOMAS A L,CASTELLANOS K,MANCINELLI G,et al.Activin A modulates inflammation in acute pancreatitis and strongly predicts severe disease independent of body mass index[J].Clin Transl Gastroenterol,2020,11(5):e00152.
[19] TURCATO G,ZABOLI A,SIBILIO S,et al.Prognostic role of albumin,lactate-to-albumin ratio and C-reactive protein-to-albumin ratio in infected patients[J].Am J Emerg Med,2024,78(1):42-47.
[20] JEON S Y,RYU S,OH S K,et al.Lactate dehydrogenase to albumin ratio as a prognostic factor for patients with severe infection requiring intensive care[J].Medicine(Baltimore),2021,100(41):e27538.
[21] CHEN Y,YANG K,WU B,et al.Association between lactate/albumin ratio and mortality in patients with heart failure after myocardial infarction[J].ESC Heart Fail,2023,10(3):1928-1936.
[22] 郭硕,吴文博,袁晨晨,等.乳酸脱氢酶与白蛋白比值对急性胰腺炎严重程度的预测价值[J].重庆医学,2023,52(18):2745-2750.
[23] SORSA T,NWHATOR S O,SAKELLARI D,et al.AMMP-8 oral fluid poc test in relation to oral and systemic diseases[J].Front Oral Health,2022,3:897115.
[24] UMEIZUDIKE K,RAISANEN I,GUPTA S,et al.Active matrix metalloproteinase-8:A potential biomarker of oral systemic link[J].Clin Exp Dent Res,2022,8(1):359-365.
[25] DE MELLO-NETO J M,NUNES J G R,TADAKAMADLA S K,et al.Immunological traits of patients with coexistent inflammatory bowel disease and periodontal disease:A systematic review[J].Int J Environ Res Public Health,2021,18(17):8958.
相似文献/References:
[1]张玉亮,朱 宏,戴洪山△.B超引导经皮经肝胆囊穿刺引流术在胆源性胰腺炎治疗中的临床意义[J].陕西医学杂志,2019,(2):166.
ZHANG Yuliang,ZHU Hong,DAI Hongshan..Clinical significance of Bmode ultrasound guided percutaneous transhepatic gallbladder puncture and
drainage in the treatment of biliary pancreatitis[J].,2019,(3):166.
[2]姜 萌,赵 鹏△.奥曲肽联合加贝酯治疗重症急性胰腺炎疗效及对患者血清细胞因子水平的影响[J].陕西医学杂志,2020,49(2):212.
JIANG Meng,ZHAO Peng..Clinical efficacy of octreotide combined with gabexate in the treatment of severe acute pancreatitis and its effect on serum cytokine levels[J].,2020,49(3):212.
[3]刘 静.红细胞分布宽度联合降钙素原检测对急性胰腺炎严重程度及预后评估价值分析[J].陕西医学杂志,2020,49(4):470.
LIU Jing..Value of Red cell distribution width combined with procalcitonin in evaluating the severity and prognosis of acute pancreatitis[J].,2020,49(3):470.
[4]朱绍华,何创业,赵 芯.血清微管相关蛋白1轻链3-Ⅱ、半胱氨酸天冬氨酸特异性蛋白酶-3及高迁移率族蛋白B1在不同程度急性胰腺炎中的表达及意义[J].陕西医学杂志,2022,51(9):1098.[doi:DOI:10.3969/j.issn.1000-7377.2022.09.012]
ZHU Shaohua,HE Chuangye,ZHAO Xin.Expression and significance of serum LC3-Ⅱ,Caspase-3 and HMGB1 in different degrees of acute pancreatitis[J].,2022,51(3):1098.[doi:DOI:10.3969/j.issn.1000-7377.2022.09.012]
[5]刘 伟,支 媛,高 璐,等.急性胰腺炎患者血清微小RNA-340-3p、CXC趋化因子配体-13和CXC趋化因子配体-16的表达意义[J].陕西医学杂志,2023,52(1):97.[doi:DOI:10.3969/j.issn.1000-7377.2023.01.023]
LIU Wei,ZHI Yuan,GAO Lu,et al.Expressions and significance of miR-340-3p,CXCL-13 and CXCL-16in serum of patients with acute pancreatitis[J].,2023,52(3):97.[doi:DOI:10.3969/j.issn.1000-7377.2023.01.023]
[6]佘育纯,路 勇,王建龙.血清基质金属蛋白酶-9、二胺氧化酶、Toll样受体9与急性胰腺炎患者疾病严重程度及肠黏膜屏障损伤相关性分析[J].陕西医学杂志,2023,52(3):292.[doi:DOI:10.3969/j.issn.1000-7377.2023.03.010]
SHE Yuchun,LU Yong,WANG Jianlong.Association of serum matrix metalloproteinase-9,diamine oxidase,and Toll-like receptor 9 with disease severity and intestinal mucosal barrier injury in patients with acute pancreatitis[J].,2023,52(3):292.[doi:DOI:10.3969/j.issn.1000-7377.2023.03.010]
[7]吕 魁,孙俊峰,杨健鹰.血清C反应蛋白、降钙素原、D-二聚体在急性胰腺炎患者中的表达及与严重程度床边指数和肺损伤的相关性[J].陕西医学杂志,2023,52(10):1375.[doi:DOI:10.3969/j.issn.1000-7377.2023.10.020]
[8]莫 闲,杨 闯.急性胰腺炎发病机制及并发内脏静脉血栓研究进展[J].陕西医学杂志,2024,(2):282.[doi:DOI:10.3969/j.issn.1000-7377.2024.02.030]
MO Xian,YANG Chuang.Research progress on pathogenesis of acute pancreatitis and concurrent splanchnic vein thrombosis[J].,2024,(3):282.[doi:DOI:10.3969/j.issn.1000-7377.2024.02.030]
[9]朱芳丽,马厉英,马晓莹,等.急性胰腺炎患者血清CXC趋化因子配体10和CC类趋化因子22水平与疾病严重程度关系及临床诊断价值研究[J].陕西医学杂志,2024,(6):788.[doi:DOI:10.3969/j.issn.1000-7377.2024.06.014]
ZHU Fangli,MA Liying,MA Xiaoying,et al.Relationship between serum CXCL10,CCL22 levels and disease severity in patients with acute pancreatitis and their clinical diagnostic value[J].,2024,(3):788.[doi:DOI:10.3969/j.issn.1000-7377.2024.06.014]